Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$544,689
-$89,273 QoQ
Shares Held
22,620
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,695
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names. PFE ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,821 | $2,494,239 | |
| 2 | ABBV |
AbbVie Inc.
|
9,472 | $2,383,534 | |
| 3 | LLY |
ELI LILLY & Co
|
1,286 | $1,542,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,280 | $806,980 | |
| 5 | PFE |
Pfizer Inc
This page
|
22,620 | $544,689 | |
| 6 | AMGN |
Amgen Inc
|
1,367 | $495,018 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,502 | $201,785 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $544,689 | 22,620 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $633,962 | 22,577 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $581,614 | 23,358 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $672,570 | 26,396 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $637,584 | 26,303 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $699,054 | 27,587 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $805,981 | 30,380 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $962,862 | 33,271 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $921,885 | 32,948 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $917,470 | 33,062 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,090,507 | 37,878 | Shares | Sole | 2024-06-17 | |
| 2023-09-30 | $1,212,164 | 36,544 | Shares | Sole | 2024-06-17 | |
| 2023-06-30 | $1,484,843 | 40,481 | Shares | Sole | 2024-06-17 | |
| 2023-03-31 | $1,645,545 | 40,332 | Shares | Sole | 2024-06-17 | |
| 2022-12-31 | $2,179,134 | 42,528 | Shares | Sole | 2024-06-17 | |
| 2022-09-30 | $1,870,871 | 42,753 | Shares | Sole | 2024-06-17 | |
| 2022-06-30 | $2,248,250 | 42,881 | Shares | Sole | 2024-06-17 | |
| 2022-03-31 | $2,103,466 | 40,631 | Shares | Sole | 2024-06-17 | |
| 2021-12-31 | $2,225,535 | 37,689 | Shares | Sole | 2024-06-17 | |
| 2021-09-30 | $1,568,273 | 36,463 | Shares | Sole | 2024-06-17 | |
| 2021-06-30 | $1,415,673 | 36,151 | Shares | Sole | 2024-06-17 | |
| 2021-03-31 | $1,355,038 | 37,401 | Shares | Sole | 2024-06-17 | |
| 2020-12-31 | $1,384,203 | 37,604 | Shares | Sole | 2024-06-17 | |
| 2020-09-30 | $1,513,726 | 41,246 | Shares | Sole | 2024-06-17 | |
| 2020-06-30 | $1,376,279 | 42,088 | Shares | Sole | 2024-06-17 | |
| 2020-03-31 | $1,413,701 | 43,312 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||